DIVA Laboratories, Ltd. (4153.TWO)

TWD 38.75

(-1.77%)

Total Liabilities Summary of DIVA Laboratories, Ltd.

  • DIVA Laboratories, Ltd.'s latest annual total liabilities in 2023 was 210.93 Million TWD , down -10.48% from previous year.
  • DIVA Laboratories, Ltd.'s latest quarterly total liabilities in 2024 Q2 was 319.34 Million TWD , up 3.51% from previous quarter.
  • DIVA Laboratories, Ltd. reported annual total liabilities of 235.61 Million TWD in 2022, up 20.66% from previous year.
  • DIVA Laboratories, Ltd. reported annual total liabilities of 195.26 Million TWD in 2021, up 57.05% from previous year.
  • DIVA Laboratories, Ltd. reported quarterly total liabilities of 219.12 Million TWD for 2024 Q3, down -31.38% from previous quarter.
  • DIVA Laboratories, Ltd. reported quarterly total liabilities of 308.51 Million TWD for 2024 Q1, up 46.26% from previous quarter.

Annual Total Liabilities Chart of DIVA Laboratories, Ltd. (2023 - 2019)

Historical Annual Total Liabilities of DIVA Laboratories, Ltd. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 210.93 Million TWD -10.48%
2022 235.61 Million TWD 20.66%
2021 195.26 Million TWD 57.05%
2020 124.33 Million TWD -26.03%
2019 168.09 Million TWD 0.0%

Peer Total Liabilities Comparison of DIVA Laboratories, Ltd.

Name Total Liabilities Total Liabilities Difference
BIONET Corp. 626.46 Million TWD 66.33%
Genetics Generation Advancement Corp. 164.9 Million TWD -27.909%
Welgene Biotech Co.,Ltd. 247.89 Million TWD 14.911%
Puriblood Medical Co., Ltd. 84.35 Million TWD -150.063%
TFBS Bioscience Inc. 187.43 Million TWD -12.535%